Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06860230 · ClinicalTrials.gov registry record
Philips FAST Evaluation
A clinical trial of Oxygen Saturation Measurement, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT06860230 is a study of Oxygen Saturation Measurement that has completed, run by Medtronic - MITG. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06860230, a study of Oxygen Saturation Measurement, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of Philips FAST technology with Nellcor sensors
Conditions Studied
Interventions
- DEVICE Philips FAST SpO2 with Nellcor Pulse Oximetry Sensors
Study Locations (1)
Colorado
- Medtronic Clinical Physiology Lab - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2025-07-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06860230
The ClinicalTrials.gov registry entry for NCT06860230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oxygen Saturation Measurement appearing as the primary indexed condition, and to 1 intervention - of which Philips FAST SpO2 with Nellcor Pulse Oximetry Sensors is the first listed.
NCT06860230 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06860230 about?
NCT06860230 is a clinical study titled "Philips FAST Evaluation". Evaluation of Philips FAST technology with Nellcor sensors
What is the current status of trial NCT06860230?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2025-03-11. Estimated completion is 2025-07-11.
What conditions does trial NCT06860230 study?
This clinical trial studies the following conditions: Oxygen Saturation Measurement.
What interventions are being tested in trial NCT06860230?
The interventions under investigation include: Philips FAST SpO2 with Nellcor Pulse Oximetry Sensors (DEVICE).
Who is sponsoring clinical trial NCT06860230?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06860230 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oxygen Saturation Measurement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.